NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
Location: United States, California, San Mateo
Funding Rounds 1
Mentions in press and media 24
|18.08.2022||Искусственный интеллект в медицине: сферы, технологии и перс...||Искусственный интеллект, внедряемый в узкоспециальных областях, оказывается перспективнее более общи...||habr.com/r...|
|26.03.2018||This is how AI will shape drug discovery||An oft-quoted statistic is that it takes 12 years and almost $2 billion dollars to bring an average ...||medcitynew...|
|09.01.2018||Andy Slavitt: When it comes to AI, it is the best of times, ...||“To some extent, [AI] is a best of times, worst of times story.” He noted that medtech advancements ...||medcitynew...|
|14.02.2017||The opportunities and challenges of AI in health care||We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an...||venturebea...|
|19.09.2015||Bursting The Top Three Myths To Get Your Healthcare Startup ...||Michael Jin Contributor
Michael Jin is a founding partner at TEEC Angel Fund.
The evolution of the...||techcrunch...|
|04.11.2013||Big data, turbo-charged. Thompson Reuters & NuMedii part...||So far, three papers have been published showing the promise of the technology’s matchmaking abiliti...||medcitynew...|
|02.08.2013||For your daily fix of inspiration and insight, follow these ...||Some of the best healthcare startup stories begin with a doctor. Frustrated by an inefficient proced...||medcitynew...|
|27.06.2013||Stanford startup NuMedii raises $3.5M in Series A to grow bi...||“NuMedii’s drug development approach is extremely capital efficient and is designed to be much more ...||medcitynew...|
|26.06.2013||NuMedii Receives $3.5M in Series A||
PALO ALTO, CA, Firm that discovers and de-risks effective new drugs by translating its predictive ...||vcnewsdail...|
|26.06.2013||NuMedii Receives $3.5M in Series A Funding||NuMedii, Inc., a Menlo Park, CA-based drug discovery company, received $3.5m in Series A funding.